Abstract
Biomarkers for Diabetes Complications: The Results of Several Clinical StudiesDiabetes is a common metabolic disorder. Its microvascular and macrovascular complications contribute to death, disabilities, and reduction in life expectancy in diabetes. It is a costly disease, and affects not only the patient and family, but also the public health, communities and society. It takes an increasing proportion of the national health care expenditure. The prevention of the development of diabetes and its complications is a major concern. Biomarkers have been investigated for understanding the mechanisms of the development and progression of diabetic complications. In this paper, the biomarkers which are recommended in the clinical practice and laboratory medicine guidelines, and which have been investigated for prediction or diagnosis of diabetes complications, have been reviewed. The results of several clinical studies will be summarized.
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Subject
Biochemistry, medical,Clinical Biochemistry
Reference62 articles.
1. International Diabetes Association. Global Burden: Prevalence and Projections, 2010 and 2030. IDF Diabetes Atlas. http://www.diabetesatlas.org/content/diabetes-and-impaired-glucose-tolerance
2. International Diabetes Association. Morbidity and Mortality. IDF Diabetes Atlas. http://www.diabetesatlas.org/content/diabetes-mortality
3. International Diabetes Association. The Economic Impacts of Diabetes. IDF Diabetes Atlas. http://www.dia-betesatlas.org/content/economic-impacts-diabetes
4. The burden of mortality attributable to diabetes: realistic estimates for the year 2000;G Roglic;Diabetes Care,2005
5. The pathobiology of diabetic complications: a unifying mechanism;M. Brownlee;Diabetes,2005
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献